Journal of Hepatocellular Carcinoma
Volume 9, 2022 - Issue
ORIGINAL RESEARCH
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Muhammad O Awiwi1 Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0001-9814-4229View further author information
https://orcid.org/0000-0001-9814-4229View further author information, Khaled M Elsayes1 Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0003-0184-0717View further author information
https://orcid.org/0000-0003-0184-0717View further author information, Yehia I Mohamed2 Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0002-5192-3804View further author information
https://orcid.org/0000-0002-5192-3804View further author information, , , Omayr Muhammad Irshad4 John Sealy School of Medicine, Galveston, TX, USAhttps://orcid.org/0000-0003-1058-3265View further author information
https://orcid.org/0000-0003-1058-3265View further author information, Ahmed Sayed Ahmed5 Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAhttps://orcid.org/0000-0001-9994-6303View further author information
https://orcid.org/0000-0001-9994-6303View further author information, & show all